Cargando…
Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome
Hydralazine, a vasodilator, is commonly used as an adjunctive treatment for moderate to severe hypertension, heart failure and hypertensive emergencies in pregnancy. Hydralazine-induced lupus was first described in 1953. Clinical presentation ranges from arthralgia, myalgia, petechiae, or rash to si...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6229221/ https://www.ncbi.nlm.nih.gov/pubmed/30413463 http://dx.doi.org/10.1136/bcr-2018-227161 |